Dai has been CEO of Micropore since 2009 and has transitioned it from lab to a growing global business offering a great value proposition to formulators of complex drug delivery systems; notably lipid nanoparticles for RNA therapies, polymer nanoparticles for nanomedicines and bioresorbable microspheres for long-acting injectable, controlled release drugs.
Dai has spent his career in chemistry and biology related businesses with companies such as Dow Chemical and Thomas Swan, including several periods overseas. He was awarded an MBE in 2019, the CDMA Golden C Award (USA) in 2003 for professional excellence in commercial development and the CIA Award in 2004. Dai is a Fellow of the Royal Society of Chemistry and was a Member of the Council of the Chemical Industries Association (1996-2005).